人雌二醇(E2)酶联免疫吸附检测试剂盒
- 货号：ELK10157
- 价格：￥2,400.00 元
- 点击：2275
产品介绍
产品信息
| 英文名称 | Human E2(Estradiol) ELISA Kit |
|---|---|
| 别名 | 17B-Estradiol; Oestradiol; Beta-Estradiol |
规格与价格
| 48T 价格 | 1680 |
|---|---|
| 96T 价格 | 2400 |
| 96T*5 价格 | 10200 |
检测参数
| 种属 | Human |
|---|---|
| 检测类型 | Competitive Inhibition |
| 灵敏度 | 12.69 pg/mL |
| 检测范围 | 46.88-3000 pg/mL |
| 样本类型 | serum, plasma, cell lysates, cell culture supernates and other biological fluids |
| 实验时长 | 2h |
研究信息
| 研究领域 | Endocrinology;Reproductive science;Hormone metabolism; |
|---|---|
| 检测原理 | This assay employs the competitive inhibition enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with Human E2. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human E2. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human E2 in the samples is then determined by comparing the OD of the samples to the standard curve. |
标准曲线
| 标准曲线图 |  |
|---|
相关产品:
| 产品名称 | 点击数 |
|---|---|
| 人无羊膜蛋白(AMN)酶联免疫吸附检测试剂盒 | 2127 |
| 人吸引素(ATRN)酶联免疫吸附检测试剂盒 | 1370 |
| 人胱天蛋白酶6(CASP6)酶联免疫吸附检测试剂盒 | 1900 |
| 人羧肽酶M(CPM)酶联免疫吸附检测试剂盒 | 2145 |
| 人肘臀蛋白(CUBN)酶联免疫吸附检测试剂盒 | 2071 |
| 人细胞球蛋白(CYGB)酶联免疫吸附检测试剂盒 | 1954 |
| 人脂筏特征蛋白2(FLOT2)酶联免疫吸附检测试剂盒 | 2458 |
| 人透明质酸合酶1(HAS1)酶联免疫吸附检测试剂盒 | 1938 |
| 人Janus激酶1(JAK1)酶联免疫吸附检测试剂盒 | 1983 |
| 人驱动蛋白2(KNS2)酶联免疫吸附检测试剂盒 | 2344 |
| 人吻素1(KISS1)酶联免疫吸附检测试剂盒 | 2027 |
| 人巯基丙酮酸硫转移酶(MPST)酶联免疫吸附检测试剂盒 | 2212 |
| 人旋光蛋白(OPTC)酶联免疫吸附检测试剂盒 | 2057 |
| 人网蛋白(PLEC)酶联免疫吸附检测试剂盒 | 1721 |
| 人核糖体结合糖蛋白Ⅰ(RPN1)酶联免疫吸附检测试剂盒 | 2054 |
| 人硫嘌呤甲基转移酶(TPMT)酶联免疫吸附检测试剂盒 | 1784 |
| 人平滑肌细胞分化特异性抗原(SMTN)酶联免疫吸附检测试剂盒 | 1711 |
| 人窖蛋白2(CAV2)酶联免疫吸附检测试剂盒 | 2123 |
| 人钙蛋白酶3(CAPN3)酶联免疫吸附检测试剂盒 | 2324 |
| 人补体成分6(C6)酶联免疫吸附检测试剂盒 | 2045 |